$UFOTRTH $UFOTRTH Trimmed down to 12 names today, right before a heavy stretch. CPI Wednesday, the SpaceX IPO Thursday, the Fed next week. Cleaned house. Sold three redundant ETFs, because paying for overlap and getting nothing back is too much like pissing into the wind. Also cut the gold. I know it’s a soft metal, but I didn’t realize how nutless and frail it had gotten. Quit acting like a hedge weeks ago and started trading like a rate bet, so it’s a hard swipe left, right next to unibrows, sea donkeys, and undercooked street meat. Added back where I actually have conviction. Planet Labs put up record revenue last night, defense and intel up 65%, and the stock sold off anyway on margins, so I bought the dip. Chicks will dig it! Leaned harder into Northrop, Lockheed, and Booz Allen for the classified side of the disclosure antics. Just wait till one of these guys drops reverse engineered tech onto the balance sheet… gasp. And I put on a managed futures position to do gold’s old job, which is to actually make money when the market rolls over. When you’re as flaccid as gold has been, it’s hard to stay up without a fluffer. There's no time for that nonsense. Every name left is big enough to move the needle, and the whole thing moves around less than it did. This is the beta and the book I want going into the next two weeks. LFG!!
The Disclosure Index
About The Disclosure Index
The Disclosure Index ($UFOTRTH) positions investors at the frontier of paradigm-shifting discovery. The fund targets high-risk, high-reward sectors most likely to be transformed by NHI and UAP disclosure, including defense, AI, cybersecurity, robotics, bioengineering, and space exploration. While disclosure represents a potential catalyst for exponential growth, the portfolio is also anchored in high-value, established companies with significant upside, ensuring investors participate in innovation and strong market performance even before a breakthrough event occurs. The portfolio is actively monitored, reallocated, and rebalanced on a regular basis to adapt to shifting market conditions and emerging opportunities, maintaining both agility and discipline in execution.About the Creator
Unusual Reports
@unusual_reports
28
Copiers
Activity
Posts by Creator
See allChanges: Sell IRDM, Sell NVDA, Buy GLD, Buy BAH, Buy MRCY $UFOTRTH With three macro catalysts stacked in a 21 day window (May CPI June 10, SpaceX IPO June 12, FOMC dot plot June 17), we are executing a tactical hedge rebalance to lock select gains, expand our gold hedge while volatility is compressed, and improve frame agnostic positioning. The fund printed +7.93% over the past week against a market up 2.39%, with the past month at +17.57% versus market +4.83%. All-time return now sits at +92.85%. This rotation moves 3.20% of book. Moves. IRDM trims from 11.76% to 9.50%, locking the gain accumulated since the Aireon acquisition drove the stock to a multi-month high at extreme premium to fair value. NVDA reduces from 8.94% to 8.00% to take beta down ahead of the Fed dot plot. GLD expands from 6.39% to 8.00% as our chaos hedge, sized while volatility remains compressed and gold has pulled back into an attractive entry. BAH increases to 9.00% as our highest conviction position across both possible disclosure outcomes, scoring at the top of our framework whether disclosure resolves toward conventional non-human intelligence contact or toward something more paradigm-altering. MRCY adds 3 basis points for advanced sensor mission computing exposure. Beta drops from approximately 1.40 to 1.30. Highlights. RKLB held at 11.62% under a raised 12% soft cap given accelerating fundamentals including the $2.2 billion backlog, $190 million DoD hypersonic contract, and $90 million Space Force GEO award. We do not trim a winner whose thesis keeps reinforcing itself. Locks IRDM strength after a sharp run on the Aireon catalyst. Gold hedge expansion is being added at a relative discount to last week. Lowlights. Trimming IRDM gives up upside if the SpaceX IPO halo extends to satellite communications. Holding NVDA at 8.00% reduces participation if AI capex acceleration continues through Q2. We accept these tradeoffs to position across the CPI and FOMC tape risk in the coming 21 days. The 60 day window remains catalyst dense. Disclosure framing continues to bifurcate. Some signals point toward conventional contact disclosure consistent with what most investors anticipate from AARO and Pentagon channels. Other signals from members of Congress increasingly reference interdimensional, consciousness-based, and biblical framings that would represent a fundamentally different paradigm. The fund is positioned to capture upside in either scenario rather than betting on one. PURSUE rolling UAP disclosure releases continue under the Trump declassification directive, the AARO 2025 annual report remains pending, SpaceX IPO June 12, two macro prints, Fed dot plot. The fund was built for this environment.
$UFOTRTH Following Rocket Lab’s Q1 earnings beat that drove RKLB up 30% intraday, we are executing a frame agnostic rebalance to lock in earnings strength, reduce concentration, and reposition for the disclosure catalyst window. The fund sits at +62.62% all time against a market up 23.33%. RKLB expanded to 16.19% of book, well above our 14% cap. This rebalance trims RKLB to 9.00%, liquidates LIT, and reduces NUKZ to 4.00% to fund five moves. BAH triples to 8.00% as our highest conviction frame agnostic position. NOC enters at 2.50% for classified space. MRCY enters at 2.50% for advanced sensor mission computing. PLTR increases to 10.50% on universal data fusion. GLD increases to 7.69% to expand chaos hedge. Dollar neutral at 14.45% rotation. Beta drops from 1.40 to approximately 1.25. Highlights. Locks in RKLB strength near $102. Liquidates LIT. Triples BAH, the only position scoring top five on both neighborly and ontological frameworks. Top four positions now within 1.22 percentage points, eliminating single name dominance. Lowlights. Selling RKLB into strength gives up upside if the rally extends. IRDM held at 10.64% despite Q1 weakness for SpaceX IPO rotation and Q2 catalysts. We accept these tradeoffs to position across multiple disclosure scenarios. The 60 day window remains the most catalyst rich since inception: Greer today, Trump declassification directive in Pentagon review, AARO’s overdue 2025 report, statutory NORAD UAP briefings, SpaceX IPO target, two FOMC meetings, and increasingly interdimensional framing from Burlison, Luna, Burchett, and Mace. The fund was built for this environment.